Penumbra Profit Margin 2014-2020 | PEN
Current and historical gross margin, operating margin and net profit margin for Penumbra (PEN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Penumbra net profit margin as of March 31, 2020 is 7.04%.
|Penumbra Annual Profit Margins
|Penumbra Quarterly Profit Margins
||Medical Instruments Manufacturing
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.